BPRMU191 is a selective μ-opioid receptor (MOR) modulator that transforms small-molecule morphinan antagonists into G protein-biased MOR agonists. This conversion facilitates MOR-dependent activation, resulting in potent analgesic effects while minimizing adverse side effects such as gastrointestinal issues, antinociceptive tolerance, and dependency risks. BPRMU191, when used in conjunction with morphinan antagonists, provides a valuable tool for exploring severe pain management and the modulation of G protein-coupled receptors in research settings.
BPRMU191 is a selective μ-opioid receptor (MOR) modulator that transforms small-molecule morphinan antagonists into G protein-biased MOR agonists. This conversion facilitates MOR-dependent activation, resulting in potent analgesic effects while minimizing adverse side effects such as gastrointestinal issues, antinociceptive tolerance, and dependency risks. BPRMU191, when used in conjunction with morphinan antagonists, provides a valuable tool for exploring severe pain management and the modulation of G protein-coupled receptors in research settings.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
